GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tascom Co Ltd (XKRX:336040) » Definitions » Other Current Payables

Tascom Co (XKRX:336040) Other Current Payables : ₩0.00 Mil (As of . 20)


View and export this data going back to 2019. Start your Free Trial

What is Tascom Co Other Current Payables?

Tascom Co's Other Current Payables for the quarter that ended in . 20 was ₩0.00 Mil.


Tascom Co Other Current Payables Historical Data

The historical data trend for Tascom Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tascom Co Other Current Payables Chart

Tascom Co Annual Data
Trend
Other Current Payables

Tascom Co Semi-Annual Data
Other Current Payables

Tascom Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Tascom Co Other Current Payables Related Terms

Thank you for viewing the detailed overview of Tascom Co's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Tascom Co Business Description

Traded in Other Exchanges
N/A
Address
43 BanPo-daero 28-gil, 5th Floor, i-SENS Building, SeoCho-gu, Seoul, KOR
Tascom Co Ltd, formerly YIDOBIO Inc is a diabetes specialty company in Korea. The company develop cell therapy for the treatment of diabetes. It also manufactures and distributes diabetic supplies. The company's products include Blood glucose measurement system-acuraview, BD Ultra Fine PRO Pen Needle, Syringes-BD Ultrafine Syringes, Ido Sharp Container, and Ido safety lancet.

Tascom Co Headlines

No Headlines